The polymerase chain reaction (PCR) is a technique that allows a millionfold, or greater, amplification of defined regions of DNA or RNA. It is potentially capable of detecting a single copy of a gene, present only once in lOS eukaryotic cells. This remarkable level of sensitivity has allowed the development of many diagnostic assays for human pathogens and disease states. These include: the detection of viral, bacterial and protozoal agents; diagnosis and genetic analysis of inherited diseases such as {3-thalassaemia, sickle cell disease, haemophilia, Tay-Sachs disease and many others; diagnosis and analysis of neoplastic disorders such as, chronic myelogenous leukaemia (CML), acute lymphocytic lymphoma (ALL), follicular lymphomas and various other cancers, including the detection of activated oncogenes; prenatal and pre-implantation diagnosis; and the development of genetic risk prediction.
INTRODUCTION Background
The polymerase chain reaction (PCR)is one of those landmark techniques that have revolutionized almost all aspects of nucleic acid analysis. Since it was first described in 1985 1 -3 , there has been an enormous increase in papers relating to the application possibilities of the PCR. This review will concentrate mainly on the clinical applications of the PCR. However, some indications of its wider use are also included in later sections.
Many clinical diagnostic assays are based on the detection of specific nucleic acid sequences. Although these techniques, such as Southern blotting or restriction fragment length polymorphism (RFLP) analysis are very successful, they all require a certain minimum amount of DNA or RNA t~work successfully (at least 1()6-10 7 copies of any given sequence). Unfortunately, it is not always Correspondence to: Dr P A Kitchin, PCR Reference Centre, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Herts EN6 3QG, UK convenient, or even possible, to obtain sufficient material for such analyses. This problem can be overcome by the use of the PCR. The PCR improves the detection limit of these assays, by at least one million-fold, because it can physically amplify trace amounts of DNA to levels that are then detectable by the more traditional means. It could, for example, produce as many as 10 9 copies from a single preexisting sequence in about 3 h.
The technique is certain to have an enormous impact upon diagnostic tests that are based on the detection of specific DNA (or RNA) sequences. The PCR is also extremely versatile and can also be performed on DNA extracted from highly degraded, fixed or ancient biological samplesv". General examples of the application possibilities for PCR are given in Table 1 . As a diagnostic test, it is still, at present, largely performed by research laboratories in association with clinicians. However, for some disease states, epidemiological analyses involving hundreds of patients have been performed, demonstrating the utility of the technique for mass screening purposes", Although there are still some problems to be overcome (see later sections), the technique is certain to find Widespread routine use in diagnostic laboratories by the end of the decade. ( ( l l l l l l l l l l l l l l l l l l l l l i ( TEMPLATE A The polymerase chain reaction
The PCR technique generates millions of copies of specific DNA sequences. This is achieved by repeated cycles of amplification ( Figure 1 ). Each cyclecauses an approximate doubling of the number of molecules of the desired sequence. A PCR cycle is composed of three separate'steps', denaturation, primer annealing, primer extension, as shown in Figure 1 .
In its simplest form, the PCR is designed to amplify target sequences from double-stranded DNA (see Figure 2 ). This could be, for example, from a region of chromosomal DNA known to harbour a mutation for an inherited disease, such as ,6-thalassaemia. In this case, 2 oligonucleotide primers of defined sequence, flanking the .a-globin gene would be synthesized. These oligonucleotides are short pieces of single-stranded DNA, normally about 20-30 nucleotides long, possessing a sequence Figure 2 . Principle of nucleic acid amplification by the polymerase chain reaction, The target DNA(strands A and B)isflanked byprimers 'a' and 'b'. During the first cycle ofPCR amplification, the strands A and Bare separated bydenaturation, the primers 'a' and 'b' anneal to their respective complementary regions andare extended to produce two new, heterogeneous length, progeny strands a l and b l • During the second cycle of amplification, the original strands A and B give rise to 2 more heterogeneous length progeny strands (a 2 and b 2 ) . However, the progeny strands from the previous cycle ta, and bl)' give rise tounique length progeny strands, a 3 
and b 3 • See text for more details.
Double stranded. DNA is indicated by 111111; progeny strands synthesized during anygiven cycle are indicated by cross-hatching, The solid region indicates thetarget DNA, The dotted arrow heads indicate thatthelength ofthe product is variable. The lower strand ofthe pair in each case is thetemplate strand and theupper strand is theprogeny synthesized during that round of amplification Figure further confirmed, even if it is of the expected size. This can be achieved by hybridization of the PCR product(s) to a radioactive oligonucleotide probe, whose sequence is specific for the desired product and internal to the primers 'a' and 'b' (see Figure 2 and This approach can be further refined to allow the rapid detection of single base changes (such as occur in ,B-thalassaemia) by using internal oligonucleotide probes that possess either the normal or the mutated sequence. These probes can readily detect the single characteristic nucleotide change and they are termed allele specific oligonucleotides (ASOs). Several other detection methods are available and these are discussed later.
Analysis of products from the PCR by (A) agarose gel electrophoresis and (B) hybridization to a radioactive, internal-specific oligonucleotide. DNA was extracted from a human cell-line (C8166) that was persistently infected with simian immunodeficiency virus(SW). SIV is the monkey equivalent ofhuman immunodeficiency virus (HIV
One of the most important aspects of the PCR is its ability to generate faithful copies of nucleic acids for subsequent sequence determination. This means that the precise genetic lesion can be readily identified, often without the need to molecularly clone the DNA product. This approach is now widely used to identify new mutations associated with disease and specific examples will be found in the following sections. 
Detection of peR product
The amount of the unique sized PCR product present after 25-40 cycles of amplification is often sufficient to allow direct visualization. This is most commonly achieved after separating the PCR products by agarose gel electrophoresis. The DNA is then stained with ethidium bromide and visualized under ultraviolet illumination (Figure 3 , panel A). The identity of the product must be complementary to regions flanking the target region of interest ('a' and 'b' in Figure 2 ).
The first 'step' of each cycle (see Figure 1 ) is to denature the double-stranded DNA by heating the sample to 94°C for 1 min, causing the two strands of chromosomal DNA to unwind and separate. This step is important, because the DNA strands are now 'free' to anneal to the oligonucleotide primers. During the second 'step' of each cycle, the primers 'a' and 'b' locate and anneal to their complementary sequences flanking the ,B-globin gene. This step is achieved by lowering the temperature of the reaction to about 55°C for 2 min. In the third and final 'step' of each cycle, the temperature is raised to noc and the primers extended by an enzyme called Taq DNA polymerase. This heat stable enzyme, now produces an exact copy of each DNA strand of, in this example, the ,B-globin gene (Figure 2 , crosshatching, al and b-).
The product obtained by copying the original chromosomal template (A and B in Figure 2 ) will always be heterogeneous in length ( Figure 2 , dotted arrow heads). This length will be dictated primarily by the processivity of the Taq polymerase. However, the product obtained when the newly synthesized strands (Figure 2 , strands al and b l) are themselves used as templates during subsequent PCR cycles, will be of a unique length (Figure 2 , strands a3 and b 3). This is because, unlike the chromosomal template, these strands have unique ends, derived from the original primer. The expected length of this unique PCR product is thus defined by the separation of the two oligonucleotide primers.
The heterogeneous length PCR product theoretically accumulates in a linear fashion with each cycle of the PCR. This is because its template can only be the original chromosomal DNA (A and B, Figure 2 ). However, the unique length product theoretically accumulates in an exponential manner with each cycle of the PCR, since every newly synthesized strand acts as a template during the next cycle of PCR amplification.
If the efficiency of the reaction is 100%, then a million-fold amplification of the target sequence can ?e achieved in just 20 cycles of the PCR. However, in practice, the efficiency is less than 100%and most amplifications are therefore performed with 25-40 cycles, to compensate for the loss of potential product at each cycle.
CLINICAL APPLICATIONS

Detection of pathogens
The peR has a major role to play in the biomedical field of detection and diagnosis of pathogens. In principle, it is capable of detecting, any and all, infectious agents, limited only by the need to know the appropriate nucleic acid sequences. The technique has been~sed to dete.ct the presence of a wide variety of viral, bactenal and protozoal pathogens from a variety of biological sources (see Table 2 for additional examples and references). The major advantage of the PCR in this area lies in its ability to demonstrate the presence of pathogens that are difficult (such as human immunodeficiency virus type 1, HTI..V-I, cytomegalovirus) or impossible (such as hepatitis B virus, human papillomav~s) to grow in tissue culture. Consequently, the~ISt presented in Table 2 is dominated largely by Viral pathogens whose detection by PCR represents an improvement over the existing techniques.
. An early application of P.CR was for !~e deteC!IOn and diagnosis of human immunodeficiency VIruS (HIV). The technique is particularly suited for this type of diagnosis, due to the latent~atur~of the virus. During the early stages of HIV infection, the virus can integrate into the host chromosomal DNA and thus become 'invisible' to the immune system. Since the PCR is easily able to detect as little as 10 integrated copies of HIV in the presence of 100,000 uninfected lymphocyte~7, it h~s~en P?ssibl~to detect HIV in a wide vanety of SItuations, mcludm~: tissue-culture cells 8 ; seronega!i~e gatients~,l ; paediatric patients11; haemophiliacs 2; acquired immunodeficiency syndrome (AIDS) and AIDSrelated complex (ARC) patients l3; and to demonstrate a dual infection with HIV-1·and HIV-2 14 • Another human retrovirus, human T-Iymphotropic virus type I (HTLV-I) has been ide~tified by PCR in association with patients suffenng from tropical spastic paraparesis (now referred to as HTLV-I associated myelopathyj'" and from pati~nts with chronic progressive myelopathy's, A particularly interesting study analysed the prevalence of human T-Iymphotropic virus type II (HTLV-II) amongst intravenous drug abusers in the New York area. This revealed 6 individuals (from a total of 169) who were triply infected with HTLV-I, HTLV-U and HIV_1 17. In these cases, the PCR was able to detect and distinguish closely related pathogens that were otherwise difficult to distinguish by serological means.
The PCR can also be used to detect pathogens in biological samples taken by non-invasive means. For example, human cytomegalovirus (CMV) c~n be detected in urine samples taken from congemtallyinfected newbornslf and Epstein-Barr virus (EBV) could be identified in throat washingsl". Such sampling techniques significantly simplify the whole diagnostic process, as well as reducing the overall costs due to the savings made in time and equipment. The human polyomaviruses, BKand IC, were also easily detected in urine samples taken from patients. This assay was further adapted to work on DNA obtained by directly boiling the samples. This allowed the assay to be performed within one day of the receipt of specimens, reduced problems associated with contamination and allowed the assay to be used in a routine manner for diagnosing polyomavirus infections-", Howe~er, unfortunately it is not always possible to obtain a PCR signal from DNA that has been prepared by directly boiling the sample. Thi~is becau~e denatured proteins and other contaminants are still present in the sample and these significantly reduce the sensitivity of the PCR. This otherwise excellent method of sample preparation, is most suited to cases where there is typically a large number of target sequences, as in the above example.
The human papillomaviruses (HPV). have been implicated in the development of anogerutal cance~.
These clinically important viruses can be rea~y detected and distinyuished by PCR in cervical scrapes and lavages-, as well as anal scrapes a~d anogenital biopsiesv. The development of rapid and specific tests of this kind will help the early detection and diagnosis of cervical and other anogenital cancers.
The PCR can also be applied to distinguish between vaccine and wild-type viruses in epidemiological studies. This is important for .the asses~ment of vaccine safety. For example, smce the introduction of a mumps vaccine in the United Kingdom in October 1988, there have been 3 cases (out of a total of 2.4 x 1()6 vaccinations) of vaccine-associated mumps meningitis. A PCR mediated analysis of the original mumps virus used for the vaccine, circulating wild-type strains and of the re-isolated strains from the vaccine-associated cases, clearly showed that these cases were all caused by the vaccine and not the circulating wild virus-'.
The PCR has been used to detect the pathogenic protozoan Toxoplasma gondii from patients with toxoplasmic encephalitis-t. This assay can improve early diagnosis for severely immunocompromised hosts, such as AIDS patients and organ transplant recipients. Other important protozoal parasites,
including Trypanosoma cruzi, the causal agent of Chagas' disease in South America, have been detected by PCR at sensitivities far in excess of previous methods". These assays have the clear potential for improving the diagnostic tests available for such parasites. The PCR can amplify DNA sequences from a wide variety of biological samples. However, among the more remarkable and important has been the discovery that the PCR can amplify DNA extracted from formalin fixed, paraffin-embedded histopathological specimens". This opens up the worldwide collection of archival, paraffin-embedded tissues, to allow studies of the association of biological agents and DNA lesions with disease. Additionally, it makes it possible to carry out retrospective studies on material where the clinical outcome has already been established. This will be especially valuable in the study of rare cancers and disease states. Such procedures have already been used successfully to detect human papillomaviruses 27 ,28, herpes simplex virus 29 and hepatitis B virus 30 , in fixed thin sections and stored paraffin blocks.
Disease diagnosis
The PCR has been applied to the diagnosis or analysis of many human disease states including inherited diseases and cancers (see Table 3 for additional examples and references). Many of the genetic lesions leading to these diseases are already known and diagnosis currently made on the basis of restriction fragment length polymorphism (RFLP) a~alysis or Southern blotting with allele specific ohgonucleotides (ASO). The PCR can be applied in almost all the cases to simplify these procedures and to considerably improve the sensitivity. For ex~mple, in some cases of haemophilia B, a charactenstic mutation in the gene for coagulation factor IX, alters the size of a diagnostic restriction fragment (RFLP). However, this RFLP is not always easy to dete~t, especially in prenatal samples. The PCR thus p~oV1des an ideal way to increase the amount of this dIagnostic fragment prior to subsequent analysis'". !iow~ver, the peR also provides the means to Identify previously unknown genetic lesions, for example, those associated with l3-thalassaemia 32 , fructose intolerances', lactic acidosis 34 and the sexlinked Fabry disease'".
A wide variety of inherited or acquired diseases have thus been analysed by PCR and the genetic lesions described. Probably all of these have the potential to provide the means for a PCR based clinical diagnostic or predictive assay. A few examples are presented below and a more comprehensive list is provided in Table 3 .
Blood related disorders: Many blood related disorders,
such as the thalassaemias and haemophilias, have been subjected to intense analysis by PCR. These important diseases are generally well suited to the development of PCR based diagnostic assays, since the mutational changes are well defined and there is normally little problem obtaining the biological sample; a single drop of blood would be sufficient in most cases. One of the first PCR mediated analyses of an inherited disease was a study of f3-thalassaemia in a group of 5 patients 36 • The gene for f3-globin was amplified and then sequenced. This analysis revealed 2 previously uncharacterized mutations along with 3 previously known alleles.
A similar approach also identified a novel mutation in the o-globin gene. This change leads to the insertion of an extra base in the gene, producing a stop codon and silencing the gene 37. A variety of mutations have also been identified in the coagulation factors VIII38 and IX 39 associated with mild and severe forms of haemophilia A and B.
Sickle cell anaemia is a genetic disease caused by a single nucleotide change in codon 6 of the f3-globin gene. This change causes an amino acid substitution (Val replaces Glu) in the f3-globin protein and this results in reduced solubility of deoxyhaemoglobin. The affected erythrocytes assume irregular shapes (classicallysickle shaped) and become trapped in the capillaries, causing multiple organ damage. This disease can be diagnosed by RFLP analysis or by the use of ASOs. Both these approaches are technically demanding and time consuming. An alternate diagnostic test has been developed using allele specific PCR which utilizes primers in which the terminal (3') nucleotide of one primer corresponds to the nucleotide found only in the normal or the mutated gene 40 , In this case, only the primer that is totally homologous will give a PCR signal. This assay is fast, very specific and gives a direct readout for the presence of the specific mutation. This type of technology is likely to replace the previous techniques for sickle cell disease analysis, Metabolic disorders: Hereditary errors of metabolism can also be analysed by PCR to define the precise genetic lesion. Once this lesion is identified, a diagnostic assay is likely to follow. For example, the hereditary basis of fructose intolerance has been established by PCR mediated sequence analysis of the aldolase B gene from affected patients. An amino acid substitution (alanine to proline) was detected at a position critical for substrate binding that inactivated this enzymeJ3. In another instance, DNA was isolated from the peripheral blood cells of a patient suffering from severe lactic acidosis, who fatigued on slight exerciseJ4. PCR amplification and sequence analysis of the pyruvate dehydrogenase gene from this patient revealed the presence of a premature stop codon that caused reduced pyruvate dehydrogenase El activity.
Large scale clinical diagnosis can sometimes be limited by the need for skilled personnel to take samples from the patients. Consequently, since PCR requires only small amounts, it could potentially be performed on samples taken for other purposes. In this respect, dried blood spots are a valuable source of biological material for PCR analysis. For example, DNA extracted from blood spots on stored Guthrie cards has been successfully analysed for mutations in the phenylalanine hydroxylase gene that lead to phenyketonuria-l. A similar approach has also been developed for the diagnosis of sickle cell disease from dried blood spots'", Otherinherited disorders: The PCR can be applied for the detection and analysis of any disease state that is characterized by a defined change in the DNA. For example, hypophosphatasia is an inherited disease (often fatal) characterized by defective bone mineralisation and a deficiency of the bone, liver and kidney alkaline phosphatase. A PCR mediated sequence analysis of cDNA from a patient revealed a guanine to adenine transition that caused a change at the amino acid level and led to inactivation of the enzymev. In a similar manner, PCR mediated analysis of RNA extracted from the fibroblasts of patients with lethal perinatal osteogenesis imperfecta revealed a spectrum of amino acid changes that disrupted collagen helix formation and led to the disease state 43 • Prenatal diagnosis: A particularly exciting area of human disease detection is the application of the PCR to prenatal and pre-implantation diagnosis. Several inherited diseases including, cystic fibrosis 44 , sickle cell diseasev, f3-thalassaemia 46 , haemophilia A47 and B48 and Huntington disease'? have been successfully diagnosed from samples of amniotic fluid or chorionic villi. Furthermore, it is also possible to detect disorders in single cells separated from the 8-16 cell stage human conceptus, before implantation into the potential motherSO,51. Whilst this pre-implantation technique remains a highly specialized procedure, it serves well to demonstrate the enormous potential of peR to facilitate procedures considered impossible even 2 years ago. PCR also provides a means for rapid prenatal sex determination'S.
Neoplastic disorders:
The PCR has a major role to play in the detection and analysis of human cancers, leukaemias and lymphomas (see Table 3 for additional examples and references). It is an ideal, and in many cases, the only technique capable of detecting sub-clinical neoplastic mutations. The application of PCR in this area is also certain to dramatically improve our knowledge on the early mutational events associated with some cancers.
The Philadelphia (Ph) chromosome is present in more than 95% of chronic myeloid leukaemia (CML) and 13% of acute lymphocytic leukaemia (ALL) patients. The Philadelphia translocation fuses the c-abl proto-oncogene from chromosome 9 to the break point cluster region (ber) of chromosome 22. This results in the production of a unique tumour specific mRNA. By the use of appropriate PCR primers it is possible to detect and distinguish these tumour specific RNA messages in a diagnostic manner 53 -55 . This technique has now been developed to allow routine monitoring after bone marrow transplantation for CML and to detect residual Ph-i-cells left after treatment56-58 • Such analyses have revealed that cells expressing the bcr/abl mRNA are not totally eradicated from the blood of CML patients in complete clinical remission even years after bone-marrow transplantation'". The significance of this observation remains to be determined.
A variety of K-Ras, N-Ras and H-Ras oncogene mutations have been characterized in DNA isolated from peripheral blood or bone marrow cells from patients with acute myelogenous leukemia (AML). PCR mediated sequencing has considerably improved the ease of Ras mutational analysis 60 and amino acid changes are found in at least 20% of all cases 61 ,62 . The detection of these mutations in peripheral blood cells thus provides a useful clinical marker for myeloid malignancy63.
The PCR has also been used to identify ras oncogene mutations associated with several stages of thyroid tumourigenesis'< and colon cancers65-67. Conversely, a PCR based analysis for activated K, Hand N ras oncogenes in 61 samples of invasive primary breast tumours, revealed only 4 instances, confirming that activating ras mutations are rarely involved in the initiation, or progression, of human breast cancers 68 • A similar conclusion was reached after an extensive analysis of primary oesophageal cancerse? and ovarian tumours'", DNA isolated from follicular lymphomas has been shown to contain a translocation of the JH4 immunoglobulin heavy chain joining (J)locus of chromosome 14, onto a region of chromosome 18. Two sites within chromosome 18 have been identified, called the major breakpoint region (mbr) or the minor cluster region (mer), which map within, or flank, the bcl-z proto-oncogene. PCR again provides a rapid, sensitive and relatively simple method to detect and analyse this translocation event for taging and monitoring follicular lymphoma and Identifying patients with sub-clinical disease 71 • 72 • Genetic risk prediction: The PCR has been used to explore the links between genetic inheritance and disease susceptibility in attempts to establish a genettc risk assessment for acquiring any given diseasa, For example, the increased incidence of Ischemic heart disease in the Afrikaner population of South Africa may, in part, be associated with two specific mutations in the low density lipoprotein Kitchin . Clinical applications of the PCR 167 (LOL) receptor gene that causes familial hypercholesterolemia (FH). The PCR has been used to detect these mutations and can help to identifl patients with an increased risk for acquiring FH7 . Using a similar approach it was also possible to obtain a risk prediction for the mild or severe forms of Gaucher's disease in Jewish patients by detecting the presence of particular mutations in the glucocerebrosidase gene 74 • The association of certain human leukocyte antigen (HLA) types with various diseases such as, rheumatoid arthritis, insulin dependent diabetes mellitus (100M) and pemphigus vulgaris has been examined by PCR. Although these sorts of diseases often have complex genetic backgrounds, it appears that certain HLA genes can be useful markers for indicating increased disease susceptibility. In the case of 100M, codon 57 (normally an aspartate residue) of the HLA OQ beta I gene appears to be a good marker for disease suceptibility. In a large scale study, 96% of 100M patients were homozygous non asp/non asp at codon 57, as compared to 19.5% in healthy patients'". Another example, the dermatological autoimmune disease, pemphigus vulgaris, appears closely associated with the presence of three specific amino acid mutations in the HLA DR Beta I gene 76 • Finally, the presence of certain OQ beta alleles appears to modify the effect of HLA OR4 beta I alleles in increasing the susceptibility to rheumatoid arthritis?". All these alleles can be easily detected by PCR analysis and thus help to provide the clinician with further information relating to risk prediction for these debilitating diseases.
The ease of analysis afforded by the PCR in these types of studies is certain to facilitate larger scale epidemiological analyses than were previously possible. This in tum will improve the data base for any given association and thus improve the value of this type of predictive analysis. It seems very likely that this is yet another area that the PCR will revolutionize during the next 10 years or so.
NON-eLiNICAL APPLICATIONS OF PCR
There is considerable overlap between clinical and non-clinical applications of the PCR and so such a division is somewhat artificial. However, this section will briefly review those applications of the PCR that are not directly relevant to the clinical setting.
Forensic science
An important non-clinical application area for PCR is in forensic analysis. The ability to amplify DNA from a huge variety of biological samples including dried blood, semen and bone'' means that the technique is certain to become indispensable. PCRaided genetic fingerprinting of individuals has been descnbed'" as well as the typing of the HLA OQ genes from a single human hair~.
A potentially serious problem with all such analyses arises from the possibility of DNA contamination generating misleading results. This is a problem that all users of PCR techniques must guard against and is discussed in more detail in a later section.
Research molecular biology
The PCR has revolutionized many standard molecular biological techniques (see Table 1 ) and an automated thermal cycler, or 'PCR machine', is now standard equipment in many laboratories. The principal roles for PCR are briefly summarized below: the technique allows rapid gene isolation and subsequent sequence analysis without the necessity for molecular cloning; it can rapidly produce large amounts of a previous~cloned DNA, obviating the need for 'mini-preps' ,81 and larger scale plasmid preparations; specific mutagenesis can be easã chieved using primers of appropriate sequences'S ; it can facilitate the isolation of related, but unknown DNA sequences; it can produce high specific activity radiolabelled probes for hybridization analysis 84 ; it can help to build large (>4kb) genomes from smaller PCR amplified regions by the use of overlapping primers; it can provide a quantitative analysis of specific DNA sequences's.
MODIFICATIONS, PRECAUTIONS AND INTERPRETATION
Modifications
The previous sections have described the most basic form of the PCR and some of the purposes for which it can be used. There are many variations of the basic procedure and a few of the more relevant ones are discussed below. Further information, beyond the scope of this review, can be obtained from various other review articles 86 -90 • RNA based peR: The PCR can be made specific for RNA, instead of DNA. This is achieved by the incorporation of a reverse transcriptase step before the first cycle of amplification?'. This converts the RNA strand into DNA, which can then be amplified as normal by the Taq polymerase. While this is technically simple to achieve, precautions must be taken, and suitable controls included, to ensure that the final PCR product does not arise from any residual DNA present in the RNA preparation. A simple way around this problem can be to amplify from genes that contain intervening sequences, or introns. These introns are normally removed (spliced) from the transcribed RNA by cellular processes, prior to translation. In such cases the PCR product derived from the spliced RNA will be smaller than the product derived from the intron containing DNA. In the case of viruses that integrate into the host DNA (for example HIV), this approach allows the distinction to be made between productive viral infection (RNA) and latent infection (DNA).
Detection techniques:
The majority of PCR based analyses have tended to use radioactivity (normally phosphorus-32) in the final detection step. However, this is not the most ideal method for a busy clinical diagnostic laboratory, because of its health hazard, short shelf life and expense. Several modifications have been devised which base the final detection step upon a colourimetric reaction with a chromogenic substrate. These techniques use oligonucleotides (either the PCR primers or the detecting oligonucleotide) that are synthesized with biotin attached. All the methods then exploit the affinity of the protein, avidin, for the biotin moiety. The PCR is performed as described previously, but the product is now detected by reaction with a conjugate of avidin linked to an enzyme, typically alkaline phosphatase (AP) or horseradish peroxidase (HRP). The AP or HRP then acts on a chromogenic substrate producing a change of colour. The technique can either be performed in liquid, or, if the PCR product is first bound onto a filter (as in a dot-blot) and a precipitating substrate used, onto a solid support'<.
This approach has been further refined by Saiki and colleagues'" to give a particularly elegant technique they term a 'reverse dot-blot'. In this format, the allele specific oligonucleotides (ASO) are given homopolymer tails (dT or dC) roughly 400 nucleotides long. Each ASO is then spotted onto a nylon strip and covalently bound by ultraviolet irradiation. Due to their length, the tails are preferentially bound, leaving the oligonucleotide probe free to hybridize. One membrane strip can thus have many different ASO 'dots', each one diagnostic for a particular mutation. The target DNA is then amplified using biotinylated PCR primers and hybridized to the membrane under stringent conditions. The PCR product will only bind to those ASOs with which it is totally homologous. The strip of ASOs can then be read for the diagnostic mutation by looking for the appropriate colour change. This approach provides for an enormous simplification in clinical diagnosis, particularly in situations where diagnosis requires the analysis of many potential single base mutations, as for example, in the case of the ,B-thalassaemias.
Biotin is by no means the only method of derivatising oligonucleotides. It is also possible to label ASOs with fluorescent dyes, such as fluorescein or rhodamine. This technique has been successfulll applied in the diagnosis of sickle cell disease? . In this case, PCR amplified products with the normal sequence fluoresce green, whereas those with the mutant sequence fluoresce red and those that are heterozygous fluoresce yellow. It is certain that this sort of technology, alongside that described above, will be the type of methodology ultimately adopted for large scale clinical diagnostic testing.
Precautions
False positive results: The enormous power of the PCR is also, unfortunately, its greatest weakness. The PCR is exquisitely sensitive to contamination with DNA from external sources. Since it is potentially capable of detecting a single specific molecule, present in the total DNA from as many as lOS eukaryotic cells, extreme care must be taken to ensure that the assay does not give misleading results. This contamination can arise from several sources, particularly when handling multiple samples sequentially. Material can easily be transferred (unknowingly) from one tube to another, from pipettes used for the assay preparation, from gloved finger-tips and on dust particles carried from one laboratory to another. Provided that a strict protocol is followed, it is possible to reduce such incidences to a minimum. However, it is absolutely essential that several types of contamination controls are included every time a PCR is performed. These should be negative controls co-processed throughout the entire template preparation, as well as assay mix only (no template) controls. The necessary additional precautions have been well described elsewhere 81 ,9s-97 and only the major points are indicated here.
It is important to separate physically the three main procedural stages of the PCR: (1) assay mix preparation; (2) template preparation and addition (pre-PCR); (3) post-PCR analysis. This is because there can easily be as many as 1()9 target molecules present in every tube after a PCR amplification, every ?ne of which is a potential template, next time a PCR IS set up. Thus, the physical separation of the post-PCR analysis laboratory from the other areas, is key to reducing contamination. Additionally, all the PCR reagents should be dedicated for the purpose, aliquoted in single use volumes and stored well ear of the post-PCR analysis laboratories. It is also likely that future laboratories offering PCR based diagnosis on a large scale will have to have separate personnel for each stage of the PCR.
The degree to which contamination is a problem is also related to the ultimate sensitivity of any particular PCR. Although the PCR is capable of detecting 10 or less target molecules in any given sample, many diagnostic tests will not require this level of sensitivity. Consequently, it is sensible to perform PCR amplifications only to the levels necessary, and no more. , The use of 'nested primers' can potentially both Improve the specificity, and reduce contamination pr?blems associated with the post PCR material. In this case, a pair of 'outer primers' is used for the first 10-15 cycles of PCR. At this point, the amount of PCR product is normally still relatively small and will not present a serious contamination threat. An aliquot from thisPCR mix is then removed and re-amplified using primers that are internal (hence the term, 'nest~d peR') to the first pair. With this strategy, the final product, now in high concentrations, Kitchin . Clinical applications of the PCR 169 cannot serve as a template for the 'outer primers' when another, 'virgin' PCR assay is set up. In certain circumstances this approach could be of considerable use, although it does obviously add to the complexity of each assay. Before the PCR can gain widespread use in clinical and diagnostic settings, the problems associated with contamination avoidance will have to be addressed and solved.
False negative results: The corollary to false positive results is, of course, the possibility of a false negative result. Such a result is most likely to arise due to the use of insufficiently homologous primers; from contaminating inhibitory material in the DNA template; or from insufficient amplification for the task in hand. If possible, the primers should always be complementary to conserved genomic sequences, to ensure they are homologous. However, since genetic variation occurs in many instances, especiallywith viruses, this can sometimes prevent primers from annealing to their targets. This problem can be partly overcome b~using primers with degenerate (inosine) bases or by using several sets of primers simultaneously". In the latter instance, the failure of one set of primers would not necessarily mean a negative result, since there would be positive signals from other sets of primers to the different regions of the target genome.
Interpretation
It is necessary to carefully establish the significance of a positive PCR assay. In many cases, this may be obvious, an individual's clinical background will match and make sense with the PCR result. However, due to the sensitivity of the assay, it is possible that some potential pathogens will be detected in, or on, otherwise apparently healthy people. What is the meaning of such a result? It may, in many cases, be clinically irrelevant. Consequently, it is necessary to establish the difference between PCR background and a relevant result. It may also be possible to be misled in certain cases. Take, for example, the case of an individual who tests PCR positive for the gag gene of HIV. Is this person actually infected? The result could be due to a defective integrated virus and thus this individual may be, neither at risk, nor truly infected.
In this type of case, it is necessary to carefully establish a strict set of criteria to accompany the interpretation of PCR diagnosis.
Considering the potential of the PCR to predict prenatal genetic predisposition to disease, it does not take a lot of imagination to foresee its ability to predict ultimately a whole manner of genetically defined traits. Given also that the entire sequence of the human genome may be available within the next 30 years, it is likely that we may approach the point where we have to decide on just exactly how much prediction we want. 
CONCLUSIONS
The polymerase chain reaction is now a very widely used general technique for the detection and analysis of .nudeic acids. It has had an enormous impact in many areas of biomedical research and it will continue to do so for many years to come. It has been widely applied for the clinical diagnosis of pathogens and disease states. In many instances it has greatly simplified the analytical procedures required and in others it provides the sole means for analysis. However, although simple in theory, the technique remains, from a routine diagnostic point of view, currently in the domain of the specialist laboratory. This is because of its susceptibility to contamination that can cause misleading results. However, procedures and precautions are becoming available to overcome these problems and it is quite conceivable that diagnostic tests for all the major (and probably the minor) disease states and pathogens will be available within the foreseeable near future. The PCR looks set to have a very bright future indeed in the sphere of new diagnostic techniques. 
